Purpose/Context.

This article discusses the various factors that have affected access to vaccines for the prevention of SARS-CoV-2 infection, with particular attention to the interests involved in the negotiations. An analysis of the processes of vaccine research, production, procurement, distribution, and marketing is detailed, as well as the international ethical standards that guide these practices.

Methodology/Approach.

Similarly, a framework of scientific, methodological, ethi-cal and legal exceptions for research, production and commercialization of vaccines is identified, while the rules imposed by the global market system regarding intellec-tual property protection (TRIPS), negotiations and contracts, defense of private and corporate interests have been maintained and deepened without exceptions. It also highlights the role played by the richest countries, accumulating more doses than necessary, which seriously impacted the access of low-income countries.

Results/Findings.

The international ethical norms and agreements made by gover-nments that should limit conducts such as these, avoid their consequences and that have not been complied with, are analyzed.

Discussion/Conclusions/Contributions.

It concludes with a concrete proposal that could alleviate the current situation and includes a reflection on the impact on the life and health of the most vulnerable countries and groups, if the international order continues to be governed by the global market system instead of a new and fairer global agreement.

        · abstract in Spanish | Portuguese     · text in Spanish     · Spanish ( pdf )